Overview

Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is to compare the efficacy and safety of increasing doses of SLV306 with amlodipine.
Phase:
Phase 2
Details
Lead Sponsor:
Solvay Pharmaceuticals